BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 19453817)

  • 1. Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil.
    Amato VS; Tuon FF; Imamura R; Abegão de Camargo R; Duarte MI; Neto VA
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1026-34. PubMed ID: 19453817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of mucocutaneous leishmaniasis with pentamidine isothionate].
    Amato V; Amato J; Nicodemo A; Uip D; Amato-Neto V; Duarte M
    Ann Dermatol Venereol; 1998 Aug; 125(8):492-5. PubMed ID: 9747313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal leishmaniasis . Current scenario and prospects for treatment.
    Amato VS; Tuon FF; Bacha HA; Neto VA; Nicodemo AC
    Acta Trop; 2008 Jan; 105(1):1-9. PubMed ID: 17884002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Bolivian mucosal leishmaniasis with miltefosine.
    Soto J; Toledo J; Valda L; Balderrama M; Rea I; Parra R; Ardiles J; Soto P; Gomez A; Molleda F; Fuentelsaz C; Anders G; Sindermann H; Engel J; Berman J
    Clin Infect Dis; 2007 Feb; 44(3):350-6. PubMed ID: 17205440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru.
    Llanos-Cuentas A; Tulliano G; Araujo-Castillo R; Miranda-Verastegui C; Santamaria-Castrellon G; Ramirez L; Lazo M; De Doncker S; Boelaert M; Robays J; Dujardin JC; Arevalo J; Chappuis F
    Clin Infect Dis; 2008 Jan; 46(2):223-31. PubMed ID: 18171254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of cutaneous and disseminated cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis in Paraty, Rio de Janeiro.
    Vieira-Gonçalves R; Pirmez C; Jorge ME; Souza WJ; Oliveira MP; Rutowitsch MS; Da-Cruz AM
    Int J Dermatol; 2008 Sep; 47(9):926-32. PubMed ID: 18937655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of cutaneous leishmaniasis in human immunodeficiency virus (HIV)-infected patients and non-HIV-infected patients in French Guiana.
    Couppié P; Clyti E; Sobesky M; Bissuel F; Del Giudice P; Sainte-Marie D; Dedet JP; Carme B; Pradinaud R
    Br J Dermatol; 2004 Dec; 151(6):1165-71. PubMed ID: 15606511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors associated with dizziness during treatment of mucosal leishmaniasis with meglumine antimoniate: 16-year retrospective study of cases from Rio de Janeiro, Brazil.
    Araujo-Melo MH; Meneses AM; Schubach AO; Moreira JS; Conceição-Silva F; Salgueiro MM; Pimentel MI; Araújo-Silva M; Oliveira RV; Carmo CN; Valete-Rosalino CM
    J Laryngol Otol; 2010 Oct; 124(10):1056-60. PubMed ID: 20537206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Good response to pentamidine isethionate in a case of Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis that was difficult to treat: Case Report.
    Ferreira Terceiro BR; Torraca TSS; Braga FPB; Martins ACDC; Brahim LR; Saheki MN; Miranda LFC; Schubach AO; Valete-Rosalino CM
    Rev Soc Bras Med Trop; 2019 Jan; 52():e20180236. PubMed ID: 30652793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mucocutaneous leishmaniasis in Brazilian Amazonia].
    Camuset G; Remy V; Hansmann Y; Christmann D; Gomes de Albuquerque C; Sena Casseb GA
    Med Mal Infect; 2007 Jun; 37(6):343-6. PubMed ID: 17512150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localized mucosal leishmaniasis due to Leishmania (Leishmania) infantum: clinical and microbiologic findings in 31 patients.
    Aliaga L; Cobo F; Mediavilla JD; Bravo J; Osuna A; Amador JM; Martín-Sánchez J; Cordero E; Navarro JM
    Medicine (Baltimore); 2003 May; 82(3):147-58. PubMed ID: 12792301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis.
    Solomon M; Baum S; Barzilai A; Scope A; Trau H; Schwartz E
    J Am Acad Dermatol; 2007 Apr; 56(4):612-6. PubMed ID: 17276541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Itraconazole in the treatment of New World mucocutaneous leishmaniasis.
    Calvopina M; Guevara AG; Armijos RX; Hashiguchi Y; Davidson RN; Cooper PJ
    Int J Dermatol; 2004 Sep; 43(9):659-63. PubMed ID: 15357745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and tolerance of pentamidine for treatment of cutaneous leishmaniasis caused by por L. (V) panamensis in Colombia].
    Robledo SM; Puerta JA; Muñoz DL; Guardo M; Vélez ID
    Biomedica; 2006 Oct; 26 Suppl 1():188-93. PubMed ID: 17361854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A
    J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study on liposomal amphotericin B and other therapies in the treatment of mucosal leishmaniasis: A 15-year retrospective cohort study.
    Santos CR; Tuon FF; Cieslinski J; de Souza RM; Imamura R; Amato VS
    PLoS One; 2019; 14(6):e0218786. PubMed ID: 31242231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-Infection of Leishmania (Viannia) braziliensis and HIV: report of a case of mucosal leishmaniasis in Cochabamba, Bolivia.
    Torrico F; Parrado R; Castro R; Marquez CJ; Torrico MC; Solano M; Reithinger R; García AL
    Am J Trop Med Hyg; 2009 Oct; 81(4):555-8. PubMed ID: 19815865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: a report of eight cases.
    Costa JM; Marsden PD; Llanos-Cuentas EA; Netto EM; Carvalho EM; Barral A; Rosa AC; Cuba CC; Magalhães AV; Barreto AC
    J Trop Med Hyg; 1986 Dec; 89(6):319-23. PubMed ID: 3806749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of extended (six weeks) treatment with miltefosine for mucosal leishmaniasis in Bolivia.
    Soto J; Rea J; Valderrama M; Toledo J; Valda L; Ardiles J; Berman J
    Am J Trop Med Hyg; 2009 Sep; 81(3):387-9. PubMed ID: 19706901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of mucosal leishmaniasis in Latin America: systematic review.
    Amato VS; Tuon FF; Siqueira AM; Nicodemo AC; Neto VA
    Am J Trop Med Hyg; 2007 Aug; 77(2):266-74. PubMed ID: 17690398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.